Dr. Tom Owens is senior counsel in the Austin office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on patent procurement and strategic IP counseling, primarily for life sciences clients. In addition to patent drafting and prosecution, Tom has broad experience in IP law practice, including drafting and negotiating licensing and other commercial agreements, performing freedom-to-operate analyses, drafting noninfringement and invalidity opinions, performing IP due diligence, and representing patent owners and patent challengers in post-grant review proceedings.
Tom has extensive experience in a variety of life sciences technologies, including immunotherapy, cell-based therapeutics, RNA therapeutics, vaccines, multi-specific antibody constructs, CAR-T therapies, drug formulations, cell culture, tissue preservation and grafting, diagnostics, biologics, cancer treatments, drug delivery technologies, bio-agriculture, microbiology, and wound healing.
Before joining the firm, Tom was a senior associate at a large international law firm practicing patent and transactional law for life sciences clients, as well as clients in the petrochemical, materials, cosmetics, and energy fields, among others. Tom’s Ph.D. research focused on cell biology, including cycle control and kinetochore structure.
Dr. Tom Owens is senior counsel in the Austin office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on patent procurement and strategic IP counseling, primarily for life sciences clients. In addition to patent drafting and prosecution, Tom has broad experience in IP law practice, including drafting and negotiating licensing and other commercial agreements, performing freedom-to-operate analyses, drafting noninfringement and invalidity opinions, performing IP due diligence, and representing patent owners and patent challengers in post-grant review proceedings.
Tom has extensive experience in a variety of life sciences technologies, including immunotherapy, cell-based therapeutics, RNA therapeutics, vaccines, multi-specific antibody constructs, CAR-T therapies, drug formulations, cell culture, tissue preservation and grafting, diagnostics, biologics, cancer treatments, drug delivery technologies, bio-agriculture, microbiology, and wound healing.
Before joining the firm, Tom was a senior associate at a large international law firm practicing patent and transactional law for life sciences clients, as well as clients in the petrochemical, materials, cosmetics, and energy fields, among others. Tom’s Ph.D. research focused on cell biology, including cycle control and kinetochore structure.
Summa Cum Laude, BYU Law Review
Summa Cum Laude, BYU Law Review